← All candidates
Two insiders bought $299.6K in a single day.
45 filings on record.
ENOVEnovis CORP
NYSE · Healthcare · $1.08B
$18.66
+4.01% · Sep 16
Two insiders bought $299.6K in a single day.
Led by McDonald Damien, chief executive officer.
Price · 1Y · daily● 11 buys● 4 sells◆ 3 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what ENOV ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.08B
Float
52.8M
91% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
5.1
Price / sales
0.5
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
EVP, Strategy & Business Dev.
Pryor Daniel A
Bought $289.0K on Aug 13 — 10,000 sh @ $28.90, held direct, 6.2% of their stake.
0 of 1 position beat the S&P
Chief Executive Officer
McDonald Damien
Bought $249.6K on Sep 4 — 13,035 sh @ $19.15, held direct, 5.3% of their stake.
0 of 1 position beat the S&P
SVP and Chief Legal Officer
Tandy Bradley J
Bought $100.5K on Aug 22 — 3,200 sh @ $31.41, held direct, 7.4% of their stake.
0 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
40 more transactions on Pro →Context
Wall St
$38.33 avg target
+105.4% vs today · 12 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
5 of 5 quarters beat
Q2 '26$0.90 act+$0.05
Q1 '26$0.89 act+$0.08
Q4 '25$0.95 act+$0.11
Q3 '25$0.75 act+$0.10
Coverage
Why Enovis (ENOV) Stock Is Trading Up TodayStockStory · 07-06Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1StockStory · 06-11Assessing Enovis (ENOV) Valuation After Recent Share Price WeaknessSimply Wall St. · 06-11Is Enovis Corporation (ENOV) a High-Growth, Under-Valued Stock?Insider Monkey · 06-09
The file stays open
45 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice